InvestorsObserver
×
News Home

Will Arca Biopharma Inc (ABIO) Stay at the Bottom of the Healthcare Sector?

Thursday, April 06, 2023 12:37 PM | InvestorsObserver Analysts

Mentioned in this article

Will Arca Biopharma Inc (ABIO) Stay at the Bottom of the Healthcare Sector?

Arca Biopharma Inc (ABIO) is near the bottom in its sector according to InvestorsObserver. ABIO gets an overall rating of 62. That means it scores higher than 62% of stocks. Arca Biopharma Inc gets a 21 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 62
ABIO has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on ABIO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Arca Biopharma Inc Stock Today?

Arca Biopharma Inc (ABIO) stock is trading at $2.00 as of 11:32 AM on Thursday, Apr 6, a rise of $0.04, or 2.31% from the previous closing price of $1.95. The stock has traded between $1.95 and $2.03 so far today. Volume today is below average. So far 15,872 shares have traded compared to average volume of 27,214 shares. Click Here to get the full Stock Report for Arca Biopharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App